IMRX · Immuneering Corp · Fails to Deliver
$3.42
-0.09 (-2.43%)
At close · Nov 19
Return incl. dividend (before tax)
Play latest call
Q3 2025 earnings call transcript
Market Cap
$220.84M
Shares
64.76M
Volume · Nov 19
201.5K
Avg daily vol (3M)
730.02K
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.
Fails to Deliver History
| Settlement Date | Quantity | Price | Value |
|---|---|---|---|
| 2026-10-30 | 5,041 | $4.02 | $20,265 |
| 2026-10-22 | 2,188 | $3.74 | $8,183 |
| 2026-10-21 | 1,748 | $3.73 | $6,520 |
| 2026-10-20 | 10 | $3.66 | $37 |
| 2026-10-16 | 14,833 | $3.64 | $53,992 |
| 2026-10-15 | 6,429 | $3.42 | $21,987 |
| 2026-10-09 | 248,059 | $3.74 | $927,741 |
| 2026-10-08 | 818 | $3.86 | $3,157 |
| 2026-10-07 | 36,955 | $3.83 | $141,538 |
| 2026-10-06 | 17,718 | $4.04 | $71,581 |
| 2026-10-02 | 36,469 | $4.03 | $146,970 |
| 2026-10-01 | 20,937 | $4.10 | $85,842 |
| 2026-09-29 | 17,411 | $4.16 | $72,430 |
| 2026-09-28 | 1,554 | $4.27 | $6,636 |
| 2026-09-24 | 14,571 | $4.38 | $63,821 |
| 2026-09-22 | 9,478 | $4.44 | $42,082 |
| 2026-09-17 | 236 | $4.45 | $1,050 |
| 2026-09-16 | 8,408 | $4.44 | $37,332 |
| 2026-09-14 | 4,502 | $4.27 | $19,224 |
| 2026-09-11 | 1,559 | $4.57 | $7,125 |
| 2026-09-10 | 77 | $4.61 | $355 |
| 2026-09-09 | 161 | $4.78 | $770 |
| 2026-09-08 | 28,017 | $4.82 | $135,042 |
| 2026-09-04 | 33,408 | $5.04 | $168,376 |
| 2026-09-03 | 46,063 | $5.02 | $231,236 |
| 2026-09-02 | 39,066 | $4.85 | $189,470 |
| 2026-08-31 | 8,663 | $4.99 | $43,228 |
| 2026-08-28 | 99 | $5.21 | $516 |
| 2026-08-27 | 41,672 | $5.15 | $214,611 |
| 2026-08-25 | 66,303 | $5.18 | $343,450 |
| 2026-08-24 | 67,401 | $5.30 | $357,225 |
| 2026-08-21 | 127 | $5.25 | $667 |
| 2026-08-20 | 33,067 | $5.33 | $176,247 |
Showing 1–33 of 33 settlements
Key facts
CIK
1790340
CUSIP
45254E107
13F (30d)
134 filings
122 filers
Visit website
Investor relations